ArticlePloS one2025
Activated human B cells produce phospholipase D4-containing extracellular vesicles.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phospholipase D4 (PLD4) is an intracellular exonuclease implicated in immune regulation via nucleic acid degradation. While public proteomic databases indicate the presence of PLD4 in human plasma, its mode of extracellular release remains unclear. This study demonstrates that activated B cells secrete PLD4-containing extracellular vesicles (EVs), providing a novel mechanism for its extracellular presence. EVs were purified from human plasma and confirmed to contain PLD4 through immunoelectron microscopy (IEM), Western blotting, and enzyme-linked immunosorbent assay. To further investigate the cellular origin, human B cells were stimulated in vitro with B cell receptor engagement and TLR9 agonist. Light and electron microscopy revealed significant cellular hypertrophy and accumulation of multivesicular bodies following stimulation. Nanoparticle tracking analysis (NTA) confirmed an increase in EV secretion, and IEM demonstrated a higher frequency of PLD4-positive EVs in stimulated B cells. Additionally, immunofluorescence and IEM revealed that PLD4 relocates from the Golgi apparatus to CD63-positive endosomes, where it is incorporated into intraluminal vesicles prior to EV release. These findings establish that activated B cells contribute to the extracellular distribution of PLD4 via EV secretion, highlighting a potential role in intercellular communication and immune regulation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.